BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7529476)

  • 1. The interferons: biological effects, mechanisms of action, and use in multiple sclerosis.
    Weinstock-Guttman B; Ransohoff RM; Kinkel RP; Rudick RA
    Ann Neurol; 1995 Jan; 37(1):7-15. PubMed ID: 7529476
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of experimental recombinant interferons on multiple sclerosis.
    Johnson KP; Panitch HS
    Trans Am Clin Climatol Assoc; 1989; 100():171-6. PubMed ID: 2479162
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon therapy for multiple sclerosis.
    Johnson KP; Panitch HS
    Md Med J; 1992 Jul; 41(7):601-3. PubMed ID: 1379317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Causal therapy of multiple sclerosis].
    Pöhlau D; Rieks M; Postert T; Hoffmann V; Przuntek H
    Dtsch Med Wochenschr; 1996 Nov; 121(45):1407-14. PubMed ID: 8964231
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interferon therapy in multiple sclerosis. Mechanism of action, side effects, results].
    Huber M
    Nervenarzt; 1988 Sep; 59(9):514-20. PubMed ID: 2460777
    [No Abstract]   [Full Text] [Related]  

  • 6. Biologic effects of interferons: relevance to multiple sclerosis.
    Rudick RA; Ransohoff RM
    Mult Scler; 1995; 1 Suppl 1():S12-6. PubMed ID: 9345391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferons in multiple sclerosis].
    Milo R; Panitch H
    Harefuah; 1994 Apr; 126(8):451-8. PubMed ID: 7520880
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon in multiple sclerosis.
    Hendel DL; Hart LL
    DICP; 1990 Feb; 24(2):158-60. PubMed ID: 1689920
    [No Abstract]   [Full Text] [Related]  

  • 9. The immunological basis of current and novel therapies of multiple sclerosis.
    Dubois B; Opdenakker G
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):7-16. PubMed ID: 11729832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferons in neurology].
    Aguilar Rebolledo F
    Rev Invest Clin; 2000; 52(6):665-79. PubMed ID: 11256110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatments for multiple sclerosis.
    Poirier J
    Axone; 1999 Mar; 20(3):78-9. PubMed ID: 10401269
    [No Abstract]   [Full Text] [Related]  

  • 12. New hope for multiple sclerosis victims via an improved, inexpensive, orthomolecular, interferon clinical protocol.
    Stone I
    Australas Nurses J; 1982 Apr; 11(3):13-5. PubMed ID: 6180724
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of interferon in multiple sclerosis.
    McFarlin DE
    Ann Neurol; 1985 Oct; 18(4):432-3. PubMed ID: 2416264
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological basis for the therapy of multiple sclerosis.
    Hohlfeld R
    Acta Neurol Belg; 1999 Mar; 99(1):40-3. PubMed ID: 10218091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug treatment in multiple sclerosis--1995].
    Achiron A
    Harefuah; 1995 Dec; 129(12):579-83. PubMed ID: 8682363
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of multiple sclerosis].
    Miyatake T
    Rinsho Shinkeigaku; 1984 Dec; 24(12):1232-4. PubMed ID: 6085568
    [No Abstract]   [Full Text] [Related]  

  • 17. Current medical treatment of multiple sclerosis.
    Alter M
    Clin Ther; 1983; 5(5):455-60. PubMed ID: 6193881
    [No Abstract]   [Full Text] [Related]  

  • 18. [Etiology and treatment of multiple sclerosis].
    Itoyama Y
    Nihon Naika Gakkai Zasshi; 2001 Sep; 90(9):1827-32. PubMed ID: 11681067
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic strategies in multiple sclerosis. I. Immunotherapy.
    Hohlfeld R
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1697-710. PubMed ID: 10603621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferons in multiple sclerosis].
    Tintoré M
    Rev Neurol; 1997 Feb; 25(138):267-9. PubMed ID: 9147755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.